5-item modified frailty index (mFI-5)

acellular Dermal Matrix (ADM)

American Society of Plastic Surgeons (ASPS)

American Society for Aesthetic Plastic Surgery (ASAPS)

anti-nuclear antibodies (ANA) 

autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 

autologous-based reconstruction (ABR)

breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) 

breast implant illness (BII) 

capsular contracture (CC)

deep inferior epigastric perforator (DIEP)

Dutch breast implant registry (DBIR)

foreign body response (FBR)

C tactile (CT) receptors

Clostridioides difficile infection (CDI)

U.S. Food and Drug Administration (FDA)

gender-affirming surgery (GAS)

inframammary fold (IMF)

lymphatic venous anastomosis (LVA)

manual lymphatic drainage (MLD)

mast cell activation syndrome (MCAS)

Mondor’s disease (MD) 

myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

N-acetyl cysteine (NAC)

nipple–areolar complex (NAC)

nonsteroidal anti-inflammatory drug (NSAID)

pectoralis major (PM) 

postural orthostatic tachycardia syndrome (POTS)

prepectoral breast reconstruction (PBR or PPBR) 

range of motion (ROM)

radiotherapy (RT)

rheumatoid arthritis (RA)

 silicone breast implant (SBI)

silicone incompatibility syndrome (SIS)

systemic autoimmune diseases (SADs)

systematic symptoms associated with breast implants (SSBI)

Selective Serotonin Reuptake Inhibitors (SSRI)

squamous cell carcinoma (SCC)

sternal notch (SN)

subpectoral breast reconstruction (SBR) 

tissue expander (TE)

undifferentiated connective tissue disease (UCTD)

Complete and Continue